Advanced in Aortic Regurgitation

Dr. Brijeshwar Maini

Cardiology
Office
4205 W Atlantic Ave Bldg B, 
Delray Beach,, FL 
Clinical Trials:Currently Recruiting for 3 Trials
Advanced in Aortic Regurgitation
Office
4205 W Atlantic Ave Bldg B, 
Delray Beach,, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Brijeshwar Maini is a Cardiologist in Delray Beach,, Florida. Dr. Maini is rated as an Advanced provider by MediFind in the treatment of Aortic Regurgitation. His top areas of expertise are Aortic Valve Stenosis, Mitral Valve Regurgitation, Atrial Fibrillation, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

His clinical research consists of co-authoring 56 peer reviewed articles and participating in 17 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Aortic Regurgitation.

Specialties
Cardiology
Licenses
Internal Medicine in FL
Hospital Affiliations
Delray Medical Center
Good Samaritan Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Denver Health Medical Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Florida Blue
  • EPO
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Rocky Mountain Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Office
4205 W Atlantic Ave Bldg B, Delray Beach,, FL 33445

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

17 Clinical Trials

Randomized Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
Randomized Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
Enrollment Status: Recruiting
Publish Date: December 11, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
Assessment of the Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild Functional Mitral Regurgitation
Assessment of the Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild Functional Mitral Regurgitation
Enrollment Status: Recruiting
Publish Date: November 10, 2025
Intervention Type: Device, Other
Study Phase: Not Applicable
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Enrollment Status: Recruiting
Publish Date: January 31, 2025
Intervention Type: Device
Study Phase: Not Applicable
Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)
Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)
Enrollment Status: Completed
Publish Date: December 15, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
WATCHMAN FLX Versus NOAC for Embolic ProtectION in in the Management of Patients With Non-Valvular Atrial Fibrillation
WATCHMAN FLX Versus NOAC for Embolic ProtectION in in the Management of Patients With Non-Valvular Atrial Fibrillation
Enrollment Status: Active_not_recruiting
Publish Date: December 15, 2025
Intervention Type: Drug, Device
Study Phase: Not Applicable
Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI)
Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI)
Enrollment Status: Active_not_recruiting
Publish Date: October 28, 2025
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement
Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement
Enrollment Status: Active_not_recruiting
Publish Date: October 21, 2025
Intervention Type: Device
Study Phase: Not Applicable
RELIEVE-HF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure
RELIEVE-HF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure
Enrollment Status: Active_not_recruiting
Publish Date: August 19, 2025
Intervention Type: Other, Device
Study Phase: Not Applicable
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
Enrollment Status: Active_not_recruiting
Publish Date: July 20, 2025
Intervention Type: Device
Study Phase: Not Applicable
Expanded Clinical Study of the Tendyne Mitral Valve System
Expanded Clinical Study of the Tendyne Mitral Valve System
Enrollment Status: Completed
Publish Date: July 17, 2025
Intervention Type: Device
Study Phase: Not Applicable
AMPLATZER™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial
AMPLATZER™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: February 26, 2025
Intervention Type: Device
Study Phase: Not Applicable
Clinical Trial to Evaluate Cardiovascular Outcomes In Patients Treated With the Tricuspid Valve Repair System Pivotal
Clinical Trial to Evaluate Cardiovascular Outcomes In Patients Treated With the Tricuspid Valve Repair System Pivotal
Enrollment Status: Active_not_recruiting
Publish Date: December 19, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Clinical Evaluation of the Safety and Effectiveness of the MitraClip® System for the Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects (COAPT Recruitment Closed). COAPT CAS (Recruitment Closed)
A Clinical Evaluation of the Safety and Effectiveness of the MitraClip® System for the Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects (COAPT Recruitment Closed). COAPT CAS (Recruitment Closed)
Enrollment Status: Unknown
Publish Date: November 27, 2023
Intervention Type: Device
Study Phase: Not Applicable
Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)
Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)
Enrollment Status: Terminated
Publish Date: June 28, 2022
Intervention Type: Device
Study Phase: Not Applicable
Protection Against Embolism for Non-valvular AF Subjects: Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology
Protection Against Embolism for Non-valvular AF Subjects: Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology
Enrollment Status: Completed
Publish Date: June 14, 2022
Intervention Type: Device
Study Phase: Not Applicable
Percutaneous Mitral Valve Replacement EvaLuation Utilizing IDE Early Feasibility Study (PRELUDE)
Percutaneous Mitral Valve Replacement EvaLuation Utilizing IDE Early Feasibility Study (PRELUDE)
Enrollment Status: Unknown
Publish Date: January 28, 2020
Intervention Type: Device
Study Phase: Not Applicable
Percutaneous Ventricular Restoration in Chronic Heart Failure Due to Ischemic Heart Disease
Percutaneous Ventricular Restoration in Chronic Heart Failure Due to Ischemic Heart Disease
Enrollment Status: Terminated
Publish Date: June 23, 2017
Intervention Type: Device
Study Phase: Phase 3
View 14 Less Clinical Trials

56 Total Publications

Comparison of Figure-of-Eight Suture and Perclose ProGlide Suture-Mediated Closure in Large Bore Venous Access Hemostasis: A Randomized Controlled Trial.
Comparison of Figure-of-Eight Suture and Perclose ProGlide Suture-Mediated Closure in Large Bore Venous Access Hemostasis: A Randomized Controlled Trial.
Journal: The American journal of cardiology
Published: September 01, 2023
Similar Doctors
Distinguished in Aortic Regurgitation
Dr. Kenneth Mandell
Cardiology
Distinguished in Aortic Regurgitation
Dr. Kenneth Mandell
Cardiology

Mandell Cardiac Care Center PA

15300 S Jog Rd Ste 202, 
Delray Beach,, FL 
 (3.8 miles away)
561-455-5601
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Kenneth Mandell is a Cardiologist in Delray Beach,, Florida. Dr. Mandell is rated as a Distinguished provider by MediFind in the treatment of Aortic Regurgitation. His top areas of expertise are Mitral Valve Regurgitation, Necrosis, Aortic Regurgitation, and Pediatric Myocarditis.

Distinguished in Aortic Regurgitation
Dr. Gonzalo Loveday
Cardiology
Distinguished in Aortic Regurgitation
Dr. Gonzalo Loveday
Cardiology

Digital Echo LLC

600 University Blvd Ste 200, 
Jupiter,, FL 
 (34.4 miles away)
561-627-2210
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Gonzalo Loveday is a Cardiologist in Jupiter,, Florida. Dr. Loveday is rated as a Distinguished provider by MediFind in the treatment of Aortic Regurgitation. His top areas of expertise are Acute Coronary Syndrome, Angina, Atherosclerosis, Coronary Heart Disease, and Pacemaker Implantation.

Distinguished in Aortic Regurgitation
Dr. Ivan Buitrago
Cardiology
Distinguished in Aortic Regurgitation
Dr. Ivan Buitrago
Cardiology

Jackson Heart Institute-Jackson South

1801 NW 9th Ave Ste 600, 
Miami, FL 
 (45.3 miles away)
305-585-4564
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ivan Buitrago is a Cardiologist in Miami, Florida. Dr. Buitrago is rated as a Distinguished provider by MediFind in the treatment of Aortic Regurgitation. His top areas of expertise are Pediatric Myocarditis, Inappropriate Sinus Tachycardia (IST), Familial Ventricular Tachycardia, and Aortic Regurgitation.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Maini's expertise for a condition
ConditionClose
    View All 29 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile